There are many reports of the treatment of amyloidosis, in the medical literature. There are several biochemical types of amyloid and the response to therapy may vary, according to type and which organ in the body is affected. There are many descriptions of the response to therapy of gastrointestinal amyloid, but fewer of response to therapy of pulmonary amyloid. Pulmonary amyloid has responded to treatment with melphalen and corticosteroids. Also pulmonary amyloidosis, associated with rheumatoid arthritis, has responded to a combination of methotrexate and Remicade® (infliximab).
For further assistance, you might want to visit the National Institutes of Health (NIH) website at, http://www.nih.gov/.
The Content on this Site is presented in a summary fashion, and is intended to be used for educational and entertainment purposes only. It is not intended to be and should not be interpreted as medical advice or a diagnosis of any health or fitness problem, condition or disease; or a recommendation for a specific test, doctor, care provider, procedure, treatment plan, product, or course of action. MedHelp is not a medical or healthcare provider and your use of this Site does not create a doctor / patient relationship. We disclaim all responsibility for the professional qualifications and licensing of, and services provided by, any physician or other health providers posting on or otherwise referred to on this Site and/or any Third Party Site. Never disregard the medical advice of your physician or health professional, or delay in seeking such advice, because of something you read on this Site. We offer this Site AS IS and without any warranties. By using this Site you agree to the following Terms and Conditions. If you think you may have a medical emergency, call your physician or 911 immediately.